BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1466279)

  • 1. Kininogens as inhibitors of calpains: characteristics and biological implications of the reaction.
    Sasaki M; Ohkubo I; Kunimatsu M
    Agents Actions Suppl; 1992; 38 ( Pt 1)():267-76. PubMed ID: 1466279
    [No Abstract]   [Full Text] [Related]  

  • 2. Interaction of human calpains I and II with high molecular weight and low molecular weight kininogens and their heavy chain: mechanism of interaction and the role of divalent cations.
    Ishiguro H; Higashiyama S; Namikawa C; Kunimatsu M; Takano E; Tanaka K; Ohkubo I; Murachi T; Sasaki M
    Biochemistry; 1987 May; 26(10):2863-70. PubMed ID: 3038169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinin release from kininogens by calpains.
    Higashiyama S; Ishiguro H; Ohkubo I; Fujimoto S; Matsuda T; Sasaki M
    Life Sci; 1986 Nov; 39(18):1639-44. PubMed ID: 3022089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contiguous binding and inhibitory sites on kininogens required for the inhibition of platelet calpain.
    Bradford HN; Jameson BA; Adam AA; Wassell RP; Colman RW
    J Biol Chem; 1993 Dec; 268(35):26546-51. PubMed ID: 8253784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of cell binding and thrombin inhibitory regions on kininogens' heavy chain.
    Jiang YP; Schmaier AH
    Agents Actions Suppl; 1992; 38 ( Pt 1)():233-40. PubMed ID: 1466275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory and antiadhesive properties of human kininogens.
    Colman RW
    Immunopharmacology; 1996 May; 32(1-3):9-18. PubMed ID: 8796259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxylated kininogens and kinins.
    Kato H; Enjyoji K
    Agents Actions Suppl; 1992; 38 ( Pt 1)():217-24. PubMed ID: 1334619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of inhibition of platelet calpain II by human kininogens.
    Bradford HN; Schmaier AH; Colman RW
    Biochem J; 1990 Aug; 270(1):83-90. PubMed ID: 2396995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of calpains and kininogens in inflammation.
    Sasaki M; Kunimatsu M; Ohkubo I
    Acta Biol Hung; 1991; 42(1-3):231-42. PubMed ID: 1844312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kininogens, kinins and kinships.
    Müller-Esterl W
    Thromb Haemost; 1989 Feb; 61(1):2-6. PubMed ID: 2665167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of thrombin-induced platelet aggregation by inhibition of calpain by a synthetic peptide derived from the thiol-protease inhibitory sequence of kininogens and S-(3-nitro-2-pyridinesulfenyl)-cysteine.
    Puri RN; Matsueda R; Umeyama H; Bradford HN; Colman RW
    Eur J Biochem; 1993 May; 214(1):233-41. PubMed ID: 8389701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping of the H-kininogen binding site exposed by the prekallikrein heavy chain.
    Herwald H; Hock H; Jahnen-Dechent W; Müller-Esterl W
    Agents Actions Suppl; 1992; 38 ( Pt 1)():225-32. PubMed ID: 1466274
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of a novel calpain inhibitor using phage display.
    Guttmann RP; Day GA; Wang X; Bottiggi KA
    Biochem Biophys Res Commun; 2005 Aug; 333(4):1087-92. PubMed ID: 15979564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuated kinin release from human neutrophil elastase-pretreated kininogens by tissue and plasma kallikreins.
    Dulinski R; Suder P; Guevara-Lora I; Rapała-Kozik M; Potempa J; Silberring J; Imamura T; Travis J; Kozik A
    Biol Chem; 2003 Jun; 384(6):929-37. PubMed ID: 12887060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High molecular weight kininogen is an inhibitor of platelet calpain.
    Schmaier AH; Bradford H; Silver LD; Farber A; Scott CF; Schutsky D; Colman RW
    J Clin Invest; 1986 May; 77(5):1565-73. PubMed ID: 2422211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloperoxidase-catalyzed oxidative inactivation of human kininogens: the impairment of kinin-precursor and prekallikrein-binding functions.
    Kozik A; Golda A; Mak P; Suder P; Silberring J; Barbasz A; Rapala-Kozik M
    Biol Chem; 2011 Mar; 392(3):263-74. PubMed ID: 21194373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinin generation from exogenous kininogens at the surface of retinoic acid-differentiated human neuroblastoma IMR-32 cells after stimulation with interferon-γ.
    Guevara-Lora I; Majkucinska M; Barbasz A; Faussner A; Kozik A
    Peptides; 2011 Jun; 32(6):1193-200. PubMed ID: 21549779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Streptococcal cysteine proteinase releases kinins: a virulence mechanism.
    Herwald H; Collin M; Müller-Esterl W; Björck L
    J Exp Med; 1996 Aug; 184(2):665-73. PubMed ID: 8760820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hybrids of chicken cystatin with human kininogen domain 2 sequences exhibit novel inhibition of calpain, improved inhibition of actinidin and impaired inhibition of papain, cathepsin L and cathepsin B.
    Auerswald EA; Nägler DK; Gross S; Assfalg-Machleidt I; Stubbs MT; Eckerskorn C; Machleidt W; Fritz H
    Eur J Biochem; 1996 Feb; 235(3):534-42. PubMed ID: 8654398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic approach for determining minimum inhibitory sequence and contribution of individual residues in binding of kininogen fragments to tissue kallikrein.
    Deshpande MS; Burton J
    Agents Actions Suppl; 1992; 38 ( Pt 1)():210-6. PubMed ID: 1466273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.